21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian Devils

      research-article
      1 , 1 , 7 , 1 , 7 , 2 , 3 , 4 , 1 , 1 , 4 , 8 , 1 , 4 , 4 , 4 , 2 , 1 , 4 , 4 , 5 , 1 , 6 , 3 , 5 , 4 , 4 , 4 , 4 , 1 , 9 ,
      Cancer Cell
      Cell Press
      cancer, Tasmanian devils, transmissible cancer, contagious cancer, DFTD, cancer evolution, cancer genomics, drug screening, conservation, marsupials

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Transmissible cancers are clonal lineages that spread through populations via contagious cancer cells. Although rare in nature, two facial tumor clones affect Tasmanian devils. Here we perform comparative genetic and functional characterization of these lineages. The two cancers have similar patterns of mutation and show no evidence of exposure to exogenous mutagens or viruses. Genes encoding PDGF receptors have copy number gains and are present on extrachromosomal double minutes. Drug screening indicates causative roles for receptor tyrosine kinases and sensitivity to inhibitors of DNA repair. Y chromosome loss from a male clone infecting a female host suggests immunoediting. These results imply that Tasmanian devils may have inherent susceptibility to transmissible cancers and present a suite of therapeutic compounds for use in conservation.

          Graphical Abstract

          Highlights

          • Tasmanian devil transmissible cancers arose from similar tissues in two individuals

          • Similar mutation patterns and driver candidates imply common oncogenic processes

          • Losses at B2M and Y chromosome loci suggest selection to escape immune detection

          • Receptor tyrosine kinases and DNA repair factors implicated as therapeutic targets

          Abstract

          Stammnitz et al. show that the two transmissible cancer clones that affect Tasmanian devils are very similar in their tissues-of-origin, mutational patterns and driver gene candidates. Importantly, these cancers are both highly sensitive to inhibitors of some receptor tyrosine kinases as well as to inhibitors of DNA repair.

          Related collections

          Most cited references58

          • Record: found
          • Abstract: found
          • Article: not found

          Targeting EZH2 in cancer.

          Recent genomic studies have resulted in an emerging understanding of the role of chromatin regulators in the development of cancer. EZH2, a histone methyl transferase subunit of a Polycomb repressor complex, is recurrently mutated in several forms of cancer and is highly expressed in numerous others. Notably, both gain-of-function and loss-of-function mutations occur in cancers but are associated with distinct cancer types. Here we review the spectrum of EZH2-associated mutations, discuss the mechanisms underlying EZH2 function, and synthesize a unifying perspective that the promotion of cancer arises from disruption of the role of EZH2 as a master regulator of transcription. We further discuss EZH2 inhibitors that are now showing early signs of promise in clinical trials and also additional strategies to combat roles of EZH2 in cancer.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Timing, rates and spectra of human germline mutation

            Germline mutations are a driving force behind genome evolution and genetic disease. We investigated genome-wide mutation rates and spectra in multi-sibling families. Mutation rate increased with paternal age in all families, but the number of additional mutations per year differed more than two-fold between families. Meta-analysis of 6,570 mutations showed that germline methylation influences mutation rates. In contrast to somatic mutations, we found remarkable consistency of germline mutation spectra between the sexes and at different paternal ages. 3.8% of mutations were mosaic in the parental germline, resulting in 1.3% of mutations being shared between siblings. The number of these shared mutations varied significantly between families. Our data suggest that the mutation rate per cell division is higher during both early embryogenesis and differentiation of primordial germ cells, but is reduced substantially during post-pubertal spermatogenesis. These findings have important consequences for the recurrence risks of disorders caused by de novo mutations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway.

              The Hippo pathway senses cell density information to control tissue growth by regulating the localization of the transcriptional regulators TAZ and YAP (TAZ/YAP). TAZ/YAP also regulate TGF-β-SMAD signaling, but whether this role is linked to cell density sensing is unknown. Here we demonstrate that TAZ/YAP dictate the localization of active SMAD complexes in response to cell density-mediated formation of polarity complexes. In high-density cell cultures, the Hippo pathway drives cytoplasmic localization of TAZ/YAP, which sequesters SMAD complexes, thereby suppressing TGF-β signaling. We show that during mouse embryogenesis, this is reflected by differences in TAZ/YAP localization, which define regions of active SMAD2/3 complexes. Interfering with TAZ/YAP phosphorylation drives nuclear accumulation of TAZ/YAP and SMAD2/3. Furthermore, we demonstrate that the Crumbs polarity complex interacts with TAZ/YAP, which relays cell density information by promoting TAZ/YAP phosphorylation, cytoplasmic retention, and suppressed TGF-β signaling. Accordingly, disruption of the Crumbs complex enhances TGF-β signaling and predisposes cells to TGF-β-mediated epithelial-to-mesenchymal transitions. Copyright © 2010 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Journal
                Cancer Cell
                Cancer Cell
                Cancer Cell
                Cell Press
                1535-6108
                1878-3686
                09 April 2018
                09 April 2018
                : 33
                : 4
                : 607-619.e15
                Affiliations
                [1 ]Transmissible Cancer Group, Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK
                [2 ]Mount Pleasant Laboratories, Tasmanian Department of Primary Industries, Parks, Water and the Environment, Prospect, TAS 7250, Australia
                [3 ]School of Health Sciences, Faculty of Health, University of Tasmania, Launceston, TAS 7248, Australia
                [4 ]Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK
                [5 ]Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS 7000, Australia
                [6 ]Centre for Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK
                Author notes
                []Corresponding author epm27@ 123456cam.ac.uk
                [7]

                These authors contributed equally

                [8]

                Present address: Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA

                [9]

                Lead Contact

                Article
                S1535-6108(18)30117-X
                10.1016/j.ccell.2018.03.013
                5896245
                29634948
                c389d3ac-072f-4c9c-a823-53f1452a79c5
                © 2018 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 14 November 2017
                : 23 January 2018
                : 11 March 2018
                Categories
                Article

                Oncology & Radiotherapy
                cancer,tasmanian devils,transmissible cancer,contagious cancer,dftd,cancer evolution,cancer genomics,drug screening,conservation,marsupials

                Comments

                Comment on this article